Daniel Joyce, MD

Daniel Joyce, MD, is an Assistant Professor in the Department of Urology at Vanderbilt University Medical Center, specializing in the treatment of kidney Cancer, testis Cancer, bladder Cancer, and prostate cancer.

Articles by Daniel Joyce, MD

Daniel Joyce, MDRenal Cell Carcinoma Diagnostics | July 9, 2024
Dr. Simpa Salami's research into a 15-gene prognostic signature for predicting ccRCC risk is discussed in this interview.
View More
Wenxin Xu, MDRenal Cell Carcinoma Diagnostics | May 28, 2024
Drs. Xu and Joyce explain the rationale behind recent research on plasma KIM-1, its significance as a biomarker, and more.
Sarah Psutka, MD, MScRenal Cell Carcinoma Diagnostics | May 7, 2024
Drs. Joyce and Psutka consider patient counseling for adjuvant RCC therapy, and biomarkers and imaging before treatment.
Abhinav Khanna, MD, MPHRenal Cell Carcinoma Diagnostics | May 14, 2024
Drs. Joyce and Khanna examine the utility of a deep learning algorithm for automated renal volume calculation.
Phillip Pierorazio, MDRenal Cell Carcinoma Diagnostics | May 14, 2024
Drs. Joyce and Pierorazio weigh appropriate surveillance versus primary intervention for clinical T1a kidney tumors.
Christopher Wallis, MD, PhD, FRCSCSUO 2023 | December 18, 2023
Drs. Joyce and Wallis consider the impact of financial toxicity and containing costs for patients with GU malignancies.